PSLIX Performance — SmallCap Fund, Institutional Class
Data updated: 2026-09-25
PSLIX returned +13.86% year to date and +27.40% over one year to Jul 2026. Annualised returns are +11.72% over 3 years and +5.92% over 5 years. The fund trailed its US Small Blend category average: $100 invested three years ago grew to $139, against $146 for the category, and to $127 over one year, against $129. Volatility over the past three years was 18.89% a year. In the 12 months to Jul 2026 the fund lost a net $392.5M, and assets reached $2.08B.
PSLIX Growth of $100
What $100 invested in SmallCap Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Small Blend category average over the same months.
| Period | PSLIX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $127 | $129 |
| 3 years (Aug 2023 – Jul 2026) | $139 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $133 | $141 |
| Since data start (Aug 2019 – Jul 2026) | $200 | $204 |
PSLIX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +13.86% |
| 1 year | +27.40% |
| 3 years (annualised) | +11.72% |
| 5 years (annualised) | +5.92% |
PSLIX Annual Returns
Calendar-year total returns of SmallCap Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +13.86% |
| 2025 | +15.12% |
| 2024 | +6.96% |
| 2023 | +15.74% |
| 2022 | −20.18% |
| 2021 | +19.96% |
| 2020 | +21.97% |
| 2019 (Aug–Dec) | +5.66% |
PSLIX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.0% | −0.9% | −5.1% | +11.4% | +2.6% | +4.9% | −3.9% | — | — | — | — | — |
| 2025 | +4.5% | −5.1% | −7.8% | −1.0% | +4.7% | +6.1% | +2.3% | +7.0% | +0.6% | +1.4% | +4.4% | −1.8% |
| 2024 | −2.2% | +5.4% | +4.4% | −7.0% | +3.5% | −1.8% | +6.9% | −0.9% | 0.0% | −1.4% | +8.5% | −7.3% |
| 2023 | +10.1% | −0.3% | −3.5% | −1.9% | −1.9% | +8.7% | +5.0% | −4.3% | −6.7% | −7.5% | +9.6% | +10.0% |
| 2022 | −9.4% | +1.4% | +0.6% | −9.4% | +0.5% | −8.9% | +10.7% | −1.6% | −9.6% | +11.4% | +1.9% | −6.6% |
| 2021 | +2.5% | +7.2% | +2.8% | +3.5% | 0.0% | +2.3% | −2.6% | +3.2% | −2.7% | +5.9% | −5.3% | +2.2% |
| 2020 | −1.3% | −8.9% | −22.7% | +14.8% | +8.7% | +3.0% | +3.2% | +6.4% | −1.2% | +0.8% | +15.9% | +7.6% |
| 2019 | — | — | — | — | — | — | — | −4.1% | +2.4% | +1.1% | +4.0% | +2.4% |
PSLIX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 18.89%
- 3-year Sharpe ratio: 0.38 (vs 4.5% risk-free rate)
- Best month: +11.40% (Apr 2026)
- Worst month: −7.80% (Mar 2025)
PSLIX Fund Flows
Monthly money in and out of SmallCap Fund, from SEC Form N-PORT.
- 12-month net flow: −$392.5M
- 12-month gross sales (incl. reinvestments): $455.9M
- Sales ÷ redemptions: 0.54×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $9.3M | $51.8M | −$42.5M |
| Jun 2026 | $18.0M | $46.9M | −$28.9M |
| May 2026 | $20.0M | $39.4M | −$19.4M |
| Apr 2026 | $10.9M | $99.0M | −$88.1M |
| Mar 2026 | $13.0M | $66.0M | −$53.0M |
| Feb 2026 | $18.7M | $169.6M | −$150.9M |
| Jan 2026 | $30.1M | $105.2M | −$75.2M |
| Dec 2025 | $146.0M | $83.5M | $62.5M |
| Nov 2025 | $24.3M | $31.1M | −$6.7M |
| Oct 2025 | $119.1M | $58.0M | $61.1M |
| Sep 2025 | $27.7M | $34.5M | −$6.7M |
| Aug 2025 | $18.8M | $63.4M | −$44.6M |
PSLIX Assets Under Management
Net assets of SmallCap Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $2.08B |
| 2026-04-30 | $2.10B |
| 2026-01-31 | $2.30B |
| 2025-10-31 | $2.26B |
| 2025-07-31 | $2.07B |
| 2025-04-30 | $1.93B |
| 2025-01-31 | $2.26B |
| 2024-10-31 | $2.28B |
| 2024-07-31 | $1.65B |
| 2024-04-30 | $1.52B |
| 2024-01-31 | $1.26B |
| 2023-10-31 | $1.06B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.